SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM 1991 Activating mutations of the stimulatory G protein in the McCune-Albright syndrome N Engl J Med 325:16881695; 1738-1740 (editorial).
  • 2
    Shenker A, Weinstein LS, Sweet DE, Spiegel AM 1994 An activating Gsα mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome J Clin Endocrinol Metab 79:750755.
  • 3
    Yamamoto T, Ozono K, Kasayama S, Yoh K, Hiroshima K, Takagi M, Matsumoto S, Michigami T, Yamaoka K, Kishimoto T, Okada S 1996 Increased IL-6 production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome J Clin Invest 98:3035.
  • 4
    Candeliere GA, Glorieux FH, Prud'homme J, St.-Arnaud R 1995 Increased expression of the c-fos proto-oncogene in bone marrow from patients with fibrous dysplasia N Engl J Med 352:15461551.
  • 5
    Kaplan FS, Fallon MD, Boden SD, Schmidt R, Senior M, Haddad JG 1988 Estrogen receptors in bone in a patient with polyostotic fibrous dysplasia (McCune-Albright syndrome) N Engl J Med 319:421425.
  • 6
    Liens D, Delmas PD, Meunier PJ 1994 Long-term effects of intravenous pamidronate in fibrous dysplasia of bone Lancet 343:953954.